Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tandem Diabetes Care (TNDM) Current Assets (2016 - 2025)

Tandem Diabetes Care's Current Assets history spans 13 years, with the latest figure at $618.1 million for Q4 2025.

  • For Q4 2025, Current Assets fell 14.68% year-over-year to $618.1 million; the TTM value through Dec 2025 reached $618.1 million, down 14.68%, while the annual FY2025 figure was $618.1 million, 14.68% down from the prior year.
  • Current Assets reached $618.1 million in Q4 2025 per TNDM's latest filing, roughly flat from $616.9 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $850.0 million in Q4 2022 to a low of $614.8 million in Q2 2025.
  • Average Current Assets over 5 years is $737.6 million, with a median of $750.4 million recorded in 2023.
  • Peak YoY movement for Current Assets: soared 135.59% in 2021, then dropped 18.05% in 2025.
  • A 5-year view of Current Assets shows it stood at $811.5 million in 2021, then grew by 4.74% to $850.0 million in 2022, then dropped by 12.0% to $748.0 million in 2023, then fell by 3.14% to $724.5 million in 2024, then fell by 14.68% to $618.1 million in 2025.
  • Per Business Quant, the three most recent readings for TNDM's Current Assets are $618.1 million (Q4 2025), $616.9 million (Q3 2025), and $614.8 million (Q2 2025).